Strategic Analysis of the Global Leukapheresis Market: Drivers, Restraints, and Opportunities
The global leukapheresis market, valued at USD 84.58 million in 2024, continues to gain strategic relevance as advanced therapies reshape clinical practice and elevate demand for high-quality cellular starting material. With a projected CAGR of 8.8%, the market’s forward momentum reflects not only uniform global expansion but also pronounced regional disparities defined by manufacturing...
0 Commentaires 0 Parts 12 Vue 0 Aperçu